Sfoglia per AUTORE
FIORINI F
Collezione ASL Vercelli

  

Items : 2

Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients. in Clinical drug investigation / Clin Drug Investig. 2017 Oct;37(10):965-973. doi: 10.1007/s40261-017-0562-8.

2017
ASL Vercelli
ASL VCO

Russo L; Borrelli S; Imperiali P; Mura C; Fiorini F; Filiberti O; Santoboni A; Canale V; Santoro D; Mele AA; Abaterusso C; Borzumati M; Bolasco P; Chiodini P; Sposini S; Minutolo R; De Nicola L; Russo D;

Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients. in American journal of kidney diseases : the official journal of the National Kidney Foundation / Am J Kidney Dis. 2016 Jul;68(1):170-2. doi: 10.1053/j.ajkd.2016.01.011. Epub 2016 Feb 13.

2016
ASL Vercelli
ASL VCO

Imperiali P; Musacchio R; Santoro D; Filiberti O; Mura C; Santoboni A; Carraro G; Abaterusso C; Sposini S; Borzumati M; Minutolo R; Fiorini F; De Nicola L; Russo D;